| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Celiac Disease | 21 | 2023 | 203 | 4.290 |
Why?
|
| Intestine, Small | 22 | 2023 | 303 | 4.150 |
Why?
|
| Capsule Endoscopy | 14 | 2023 | 33 | 3.420 |
Why?
|
| Endoscopy, Gastrointestinal | 17 | 2021 | 153 | 3.310 |
Why?
|
| Gastrointestinal Hemorrhage | 12 | 2023 | 229 | 2.170 |
Why?
|
| Double-Balloon Enteroscopy | 5 | 2021 | 11 | 1.750 |
Why?
|
| Intestinal Diseases | 4 | 2021 | 79 | 1.640 |
Why?
|
| Nutrition Therapy | 3 | 2020 | 11 | 1.530 |
Why?
|
| Parenteral Nutrition | 5 | 2024 | 60 | 1.360 |
Why?
|
| Diet, Gluten-Free | 7 | 2023 | 52 | 1.200 |
Why?
|
| Gastroenterologists | 3 | 2022 | 30 | 1.030 |
Why?
|
| Intestinal Neoplasms | 2 | 2020 | 56 | 1.030 |
Why?
|
| Intestinal Mucosa | 11 | 2020 | 797 | 1.000 |
Why?
|
| Gastroenterology | 5 | 2022 | 134 | 0.990 |
Why?
|
| Short Bowel Syndrome | 3 | 2020 | 37 | 0.940 |
Why?
|
| Doxycycline | 2 | 2013 | 27 | 0.920 |
Why?
|
| Gastric Mucosa | 3 | 2013 | 66 | 0.900 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2013 | 62 | 0.880 |
Why?
|
| Osteoporosis | 2 | 2019 | 121 | 0.870 |
Why?
|
| Nutritional Sciences | 2 | 2018 | 12 | 0.770 |
Why?
|
| Nutrition Assessment | 1 | 2020 | 21 | 0.760 |
Why?
|
| Carcinoid Tumor | 1 | 2020 | 42 | 0.740 |
Why?
|
| Bone Resorption | 1 | 2019 | 41 | 0.700 |
Why?
|
| Crohn Disease | 4 | 2020 | 730 | 0.690 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2019 | 33 | 0.690 |
Why?
|
| Adenoma | 1 | 2020 | 235 | 0.640 |
Why?
|
| Anti-Bacterial Agents | 2 | 2013 | 746 | 0.620 |
Why?
|
| Osteogenesis | 1 | 2019 | 242 | 0.610 |
Why?
|
| Humans | 66 | 2024 | 86644 | 0.600 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.600 |
Why?
|
| Enteral Nutrition | 3 | 2016 | 102 | 0.600 |
Why?
|
| Intensive Care Units | 1 | 2020 | 373 | 0.590 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 108 | 0.580 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 369 | 0.580 |
Why?
|
| Glutens | 7 | 2023 | 76 | 0.580 |
Why?
|
| Esophagitis | 2 | 2013 | 42 | 0.570 |
Why?
|
| Gastrointestinal Agents | 2 | 2020 | 161 | 0.560 |
Why?
|
| Metabolic Syndrome | 1 | 2017 | 141 | 0.550 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.520 |
Why?
|
| Peptides | 3 | 2020 | 639 | 0.510 |
Why?
|
| Adenocarcinoma | 3 | 2020 | 1169 | 0.510 |
Why?
|
| Embolization, Therapeutic | 1 | 2016 | 238 | 0.470 |
Why?
|
| Transglutaminases | 3 | 2020 | 39 | 0.390 |
Why?
|
| Gastrointestinal Diseases | 4 | 2014 | 146 | 0.390 |
Why?
|
| Risk Factors | 9 | 2020 | 5417 | 0.380 |
Why?
|
| Jejunum | 1 | 2010 | 79 | 0.380 |
Why?
|
| Retrospective Studies | 12 | 2024 | 8489 | 0.380 |
Why?
|
| Aged, 80 and over | 10 | 2020 | 6509 | 0.350 |
Why?
|
| Jejunal Neoplasms | 1 | 2009 | 9 | 0.350 |
Why?
|
| Duodenal Neoplasms | 1 | 2009 | 19 | 0.350 |
Why?
|
| Ileal Neoplasms | 1 | 2009 | 9 | 0.350 |
Why?
|
| Intestinal Perforation | 1 | 2009 | 34 | 0.350 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 69 | 0.350 |
Why?
|
| Female | 27 | 2023 | 44533 | 0.340 |
Why?
|
| Pancreatitis | 1 | 2009 | 87 | 0.340 |
Why?
|
| Endoscopes, Gastrointestinal | 2 | 2007 | 8 | 0.330 |
Why?
|
| Bone Density | 2 | 2019 | 209 | 0.330 |
Why?
|
| Monitoring, Physiologic | 1 | 2009 | 268 | 0.310 |
Why?
|
| Gastrostomy | 3 | 2016 | 69 | 0.300 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 469 | 0.300 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2015 | 315 | 0.300 |
Why?
|
| Middle Aged | 20 | 2023 | 25028 | 0.290 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 160 | 0.290 |
Why?
|
| Catheterization | 4 | 2009 | 232 | 0.270 |
Why?
|
| Obesity | 3 | 2017 | 963 | 0.270 |
Why?
|
| Adult | 19 | 2023 | 25648 | 0.260 |
Why?
|
| Aged | 15 | 2023 | 18415 | 0.250 |
Why?
|
| Interleukin-15 | 3 | 2015 | 72 | 0.250 |
Why?
|
| Male | 23 | 2023 | 40966 | 0.250 |
Why?
|
| Inflammation | 3 | 2019 | 920 | 0.230 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2023 | 19 | 0.220 |
Why?
|
| Diarrhea | 2 | 2014 | 182 | 0.210 |
Why?
|
| Young Adult | 6 | 2020 | 5976 | 0.210 |
Why?
|
| Registries | 2 | 2020 | 702 | 0.200 |
Why?
|
| HLA-DQ Antigens | 2 | 2019 | 52 | 0.200 |
Why?
|
| Calcium | 3 | 2019 | 1156 | 0.190 |
Why?
|
| Sweden | 1 | 2020 | 40 | 0.190 |
Why?
|
| Deficiency Diseases | 1 | 1999 | 10 | 0.180 |
Why?
|
| Antigens | 2 | 2019 | 228 | 0.180 |
Why?
|
| Zinc | 1 | 1999 | 91 | 0.170 |
Why?
|
| Th1 Cells | 2 | 2017 | 164 | 0.170 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2019 | 70 | 0.170 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 23 | 0.170 |
Why?
|
| Osteoporotic Fractures | 1 | 2019 | 38 | 0.170 |
Why?
|
| Atrophy | 1 | 2018 | 117 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2019 | 102 | 0.160 |
Why?
|
| Gastrointestinal Hormones | 1 | 1997 | 6 | 0.160 |
Why?
|
| Reoviridae Infections | 1 | 2017 | 7 | 0.150 |
Why?
|
| Avena | 1 | 2017 | 17 | 0.150 |
Why?
|
| Fatal Outcome | 2 | 2016 | 293 | 0.150 |
Why?
|
| Vitamin D | 1 | 2019 | 261 | 0.150 |
Why?
|
| Intestinal Absorption | 3 | 2019 | 124 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2020 | 814 | 0.140 |
Why?
|
| Autoantibodies | 3 | 2020 | 267 | 0.140 |
Why?
|
| Vital Capacity | 1 | 2016 | 64 | 0.140 |
Why?
|
| United States | 6 | 2015 | 6672 | 0.140 |
Why?
|
| Curriculum | 2 | 2018 | 539 | 0.140 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2016 | 27 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2022 | 1036 | 0.140 |
Why?
|
| Leukotrienes | 1 | 2015 | 20 | 0.140 |
Why?
|
| Equipment Design | 3 | 2019 | 406 | 0.140 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2015 | 29 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2017 | 7993 | 0.130 |
Why?
|
| Malnutrition | 1 | 2016 | 34 | 0.130 |
Why?
|
| Attitude | 1 | 2016 | 127 | 0.130 |
Why?
|
| Overweight | 1 | 2016 | 118 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2019 | 535 | 0.130 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2016 | 182 | 0.130 |
Why?
|
| Adolescent | 6 | 2016 | 8981 | 0.130 |
Why?
|
| Biopsy | 4 | 2019 | 1163 | 0.130 |
Why?
|
| Cysteine | 1 | 2015 | 135 | 0.130 |
Why?
|
| Immunoglobulin A | 2 | 2020 | 80 | 0.120 |
Why?
|
| Cell Communication | 1 | 2015 | 194 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2015 | 164 | 0.120 |
Why?
|
| Abdominal Pain | 2 | 2013 | 137 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 1673 | 0.120 |
Why?
|
| Mentors | 1 | 2014 | 76 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 2601 | 0.120 |
Why?
|
| Capsule Endoscopes | 1 | 2013 | 5 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2015 | 227 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 711 | 0.110 |
Why?
|
| Child | 4 | 2023 | 6927 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 493 | 0.110 |
Why?
|
| Endoscopy, Digestive System | 1 | 2013 | 65 | 0.110 |
Why?
|
| Risk Assessment | 1 | 2020 | 2261 | 0.110 |
Why?
|
| Capillaries | 1 | 2013 | 91 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2014 | 178 | 0.110 |
Why?
|
| Necrosis | 1 | 2013 | 204 | 0.110 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 71 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2016 | 2207 | 0.110 |
Why?
|
| Withholding Treatment | 1 | 2013 | 112 | 0.100 |
Why?
|
| Cystic Fibrosis | 1 | 1993 | 112 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 3362 | 0.100 |
Why?
|
| Carrier Proteins | 3 | 1996 | 673 | 0.100 |
Why?
|
| Stomach | 2 | 2010 | 108 | 0.100 |
Why?
|
| Time Factors | 1 | 2020 | 5210 | 0.100 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2011 | 92 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 2 | 2022 | 144 | 0.100 |
Why?
|
| Remission Induction | 1 | 2013 | 722 | 0.100 |
Why?
|
| Jejunostomy | 1 | 2010 | 14 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2015 | 669 | 0.100 |
Why?
|
| Angiography | 1 | 2011 | 208 | 0.100 |
Why?
|
| Sodium | 2 | 2000 | 341 | 0.100 |
Why?
|
| Consensus | 2 | 2022 | 335 | 0.100 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1990 | 39 | 0.090 |
Why?
|
| Ileostomy | 1 | 2010 | 30 | 0.090 |
Why?
|
| Tretinoin | 1 | 2011 | 126 | 0.090 |
Why?
|
| Adjuvants, Immunologic | 1 | 2011 | 167 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2012 | 695 | 0.090 |
Why?
|
| Parenteral Nutrition, Home | 1 | 2009 | 1 | 0.090 |
Why?
|
| Intestinal Polyposis | 1 | 2009 | 2 | 0.090 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.090 |
Why?
|
| Gastric Balloon | 1 | 2009 | 1 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 2 | 2006 | 31 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 827 | 0.090 |
Why?
|
| Neoplasms | 1 | 2024 | 2898 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2020 | 1805 | 0.080 |
Why?
|
| Quality of Life | 1 | 2016 | 1585 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2009 | 319 | 0.080 |
Why?
|
| GTP-Binding Proteins | 2 | 2020 | 146 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3640 | 0.070 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 2006 | 26 | 0.070 |
Why?
|
| Intestinal Obstruction | 1 | 2007 | 88 | 0.070 |
Why?
|
| Duodenal Obstruction | 1 | 2006 | 4 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 865 | 0.070 |
Why?
|
| Cyclic AMP | 1 | 1987 | 273 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2019 | 971 | 0.070 |
Why?
|
| Ileocecal Valve | 1 | 2005 | 5 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 645 | 0.070 |
Why?
|
| Gastric Bypass | 1 | 2006 | 110 | 0.070 |
Why?
|
| Patient Selection | 1 | 2009 | 685 | 0.070 |
Why?
|
| Biological Transport | 2 | 1999 | 396 | 0.060 |
Why?
|
| Ileum | 2 | 2019 | 159 | 0.060 |
Why?
|
| Chicago | 1 | 2009 | 1379 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2006 | 267 | 0.060 |
Why?
|
| Palliative Care | 1 | 2006 | 257 | 0.060 |
Why?
|
| Stents | 1 | 2006 | 377 | 0.060 |
Why?
|
| Endoscopy | 1 | 2006 | 332 | 0.060 |
Why?
|
| Interferon-gamma | 2 | 2006 | 444 | 0.060 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 43 | 0.060 |
Why?
|
| Virus Activation | 1 | 2003 | 41 | 0.060 |
Why?
|
| Hepatitis B | 1 | 2003 | 74 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2023 | 179 | 0.050 |
Why?
|
| Advisory Committees | 1 | 2022 | 90 | 0.050 |
Why?
|
| Immune Tolerance | 2 | 2017 | 337 | 0.050 |
Why?
|
| Animals | 9 | 2017 | 26582 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2003 | 151 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 294 | 0.050 |
Why?
|
| Chlorides | 3 | 2000 | 103 | 0.050 |
Why?
|
| Diet | 2 | 2017 | 443 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2015 | 3241 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2023 | 191 | 0.050 |
Why?
|
| Ions | 1 | 2000 | 74 | 0.050 |
Why?
|
| Thymidine Phosphorylase | 1 | 2000 | 5 | 0.050 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2000 | 5 | 0.050 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2000 | 5 | 0.050 |
Why?
|
| Saccharomyces | 1 | 2020 | 21 | 0.050 |
Why?
|
| Antibodies | 1 | 2022 | 350 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 1540 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1578 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1996 | 989 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1458 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 99 | 0.040 |
Why?
|
| Biological Availability | 1 | 1999 | 92 | 0.040 |
Why?
|
| Duodenum | 1 | 2019 | 100 | 0.040 |
Why?
|
| Butyrophilins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Amiloride | 2 | 1990 | 36 | 0.040 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2019 | 16 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2000 | 504 | 0.040 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 1990 | 79 | 0.040 |
Why?
|
| Fractures, Bone | 1 | 2000 | 131 | 0.040 |
Why?
|
| Chickens | 2 | 1990 | 212 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1996 | 1196 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2818 | 0.040 |
Why?
|
| Enterochromaffin Cells | 1 | 1997 | 2 | 0.040 |
Why?
|
| Imidazoles | 2 | 1990 | 162 | 0.040 |
Why?
|
| Natriuretic Peptides | 1 | 1997 | 6 | 0.040 |
Why?
|
| Chloride Channels | 2 | 1996 | 42 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 3092 | 0.040 |
Why?
|
| Non-Randomized Controlled Trials as Topic | 1 | 2017 | 6 | 0.040 |
Why?
|
| Reoviridae | 1 | 2017 | 6 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2017 | 19 | 0.040 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2017 | 20 | 0.040 |
Why?
|
| Stomach Diseases | 1 | 1997 | 19 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2767 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 1997 | 290 | 0.040 |
Why?
|
| Visual Analog Scale | 1 | 2016 | 14 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1313 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 48 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2019 | 264 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 615 | 0.040 |
Why?
|
| Sarcoidosis | 1 | 1997 | 71 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2017 | 114 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 372 | 0.040 |
Why?
|
| Lauric Acids | 1 | 1996 | 1 | 0.040 |
Why?
|
| Interferon Type I | 1 | 2017 | 175 | 0.040 |
Why?
|
| Receptors, Purinergic P2 | 1 | 1996 | 15 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 849 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2011 | 1106 | 0.030 |
Why?
|
| Receptors, Leukotriene | 1 | 2015 | 10 | 0.030 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2015 | 22 | 0.030 |
Why?
|
| Nutrition Surveys | 1 | 2016 | 114 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 58 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 128 | 0.030 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2015 | 33 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 106 | 0.030 |
Why?
|
| Ion Channels | 2 | 1996 | 246 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 3030 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 1991 | 0.030 |
Why?
|
| Molecular Chaperones | 1 | 2015 | 111 | 0.030 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2015 | 113 | 0.030 |
Why?
|
| Steatorrhea | 1 | 2014 | 2 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2014 | 7 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 179 | 0.030 |
Why?
|
| Breath Tests | 1 | 2014 | 55 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 41 | 0.030 |
Why?
|
| Peptide Hormones | 1 | 2014 | 29 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2014 | 175 | 0.030 |
Why?
|
| Intestines | 1 | 2017 | 411 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 61 | 0.030 |
Why?
|
| History, 20th Century | 1 | 2014 | 312 | 0.030 |
Why?
|
| China | 1 | 2014 | 228 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1019 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1718 | 0.030 |
Why?
|
| Endocytosis | 1 | 1994 | 177 | 0.030 |
Why?
|
| Research Design | 2 | 2006 | 594 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 455 | 0.030 |
Why?
|
| Mice | 3 | 2017 | 11352 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 1538 | 0.030 |
Why?
|
| Operative Time | 1 | 2013 | 127 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 770 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 712 | 0.030 |
Why?
|
| Smoking | 1 | 2016 | 609 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 319 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 1997 | 1981 | 0.030 |
Why?
|
| Receptors, Interleukin-12 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2011 | 24 | 0.020 |
Why?
|
| Gliadin | 1 | 2011 | 17 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1990 | 13 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 2010 | 9 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2016 | 1143 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 164 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.020 |
Why?
|
| Interleukin-23 | 1 | 2011 | 54 | 0.020 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 1990 | 58 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2011 | 108 | 0.020 |
Why?
|
| Isoquinolines | 1 | 1990 | 72 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 2232 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2016 | 751 | 0.020 |
Why?
|
| Diverticulum | 1 | 2010 | 44 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 166 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2010 | 157 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 684 | 0.020 |
Why?
|
| Mutation | 1 | 2000 | 3968 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1993 | 2062 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 2378 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 806 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 2501 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 295 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1141 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2011 | 425 | 0.020 |
Why?
|
| Nigericin | 1 | 1987 | 2 | 0.020 |
Why?
|
| Valinomycin | 1 | 1987 | 8 | 0.020 |
Why?
|
| Calcimycin | 1 | 1987 | 33 | 0.020 |
Why?
|
| Aminoquinolines | 1 | 1987 | 17 | 0.020 |
Why?
|
| Buffers | 1 | 1987 | 26 | 0.020 |
Why?
|
| Alprostadil | 1 | 1987 | 25 | 0.020 |
Why?
|
| Butyrates | 1 | 1987 | 42 | 0.020 |
Why?
|
| Glycine | 1 | 1987 | 92 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 69 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2016 | 1004 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2006 | 119 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 45 | 0.020 |
Why?
|
| North America | 1 | 2006 | 180 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 135 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 134 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 2006 | 144 | 0.020 |
Why?
|
| Weight Loss | 1 | 2006 | 229 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2006 | 177 | 0.020 |
Why?
|
| Lymphoma | 1 | 2006 | 262 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 3612 | 0.010 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 225 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 371 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 754 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 2330 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 2003 | 140 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 102 | 0.010 |
Why?
|
| Blepharoptosis | 1 | 2000 | 11 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 135 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2000 | 78 | 0.010 |
Why?
|
| Ophthalmoplegia | 1 | 2000 | 11 | 0.010 |
Why?
|
| Mitochondria, Muscle | 1 | 2000 | 26 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2000 | 92 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1384 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2000 | 87 | 0.010 |
Why?
|
| Cell Line | 2 | 1996 | 2468 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 117 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 205 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 310 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 281 | 0.010 |
Why?
|
| Point Mutation | 1 | 2000 | 246 | 0.010 |
Why?
|
| Syndrome | 1 | 2000 | 446 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 289 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 943 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 450 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 4214 | 0.010 |
Why?
|
| Liver | 1 | 2003 | 1230 | 0.010 |
Why?
|
| Glucose | 1 | 2000 | 638 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 1920 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 449 | 0.010 |
Why?
|
| Proteolipids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 8 | 0.010 |
Why?
|
| Uncoupling Protein 1 | 1 | 1996 | 35 | 0.010 |
Why?
|
| Uridine Triphosphate | 1 | 1996 | 5 | 0.010 |
Why?
|
| Receptors, Purinergic P2X7 | 1 | 1996 | 9 | 0.010 |
Why?
|
| Anions | 1 | 1996 | 31 | 0.010 |
Why?
|
| Photochemistry | 1 | 1996 | 38 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1996 | 107 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1996 | 26 | 0.010 |
Why?
|
| Ion Transport | 1 | 1996 | 81 | 0.010 |
Why?
|
| Xenopus | 1 | 1996 | 125 | 0.010 |
Why?
|
| Adipose Tissue, Brown | 1 | 1996 | 80 | 0.010 |
Why?
|
| Protons | 1 | 1996 | 98 | 0.010 |
Why?
|
| Connexin 43 | 1 | 1996 | 94 | 0.010 |
Why?
|
| Cricetinae | 1 | 1996 | 560 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1996 | 123 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1996 | 193 | 0.010 |
Why?
|
| Radiography | 1 | 1997 | 813 | 0.010 |
Why?
|
| Oocytes | 1 | 1996 | 221 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1996 | 314 | 0.010 |
Why?
|
| Receptors, Transferrin | 1 | 1994 | 10 | 0.010 |
Why?
|
| Wheat Germ Agglutinins | 1 | 1994 | 16 | 0.010 |
Why?
|
| Transferrin | 1 | 1994 | 19 | 0.010 |
Why?
|
| Colforsin | 1 | 1994 | 74 | 0.010 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 1994 | 57 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2262 | 0.010 |
Why?
|
| Iron | 1 | 1994 | 164 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 1098 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 425 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 1041 | 0.010 |
Why?
|
| Transfection | 1 | 1994 | 896 | 0.010 |
Why?
|
| Kinetics | 1 | 1994 | 1513 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1994 | 666 | 0.010 |
Why?
|